The POU transcription factor Oct-4 is expressed in early mouse embryogenesis and in pluripotent embryonic stem (ES) and embryonic carcinoma (EC) stem cell lines. After gastrulation in the embryo, Oct-4 expression is confined to the germline. The present study provides evidence that Oct-4 undergoes downregulation during oogenesis and spermatogenesis, coincident with entry into meiosis. Furthermore, analysis of maturation stages of oocytes showed that Oct-4 is upregulated de novo in the final stages of meiotic prophase I in female germ cells. These data suggest that Oct-4 downregulation in germ cells in both sexes might represent one of the molecular triggers involved in the commitment to meiosis. The upregulation of Oct-4 in oocytes at the completion of the prophase I of meiotic division further suggests a specific involvement of this transcription factor in oocyte growth or the acquisition of meiotic competence.
Introduction
Oct-4 belongs to class V of the POU transcription factor family (Schöler et al., 1990b) . POU factors all share a multifunctional bipartite domain, composed of a POU homeodomain and a POU-specific domain. The POU domain is essential for binding to DNA through the canonical octamer motif sequence ATGCAAAT or related sequences (Herr and McCleary, 1995) . In addition, the POU domain interacts with coactivators which can modulate the activity of these factors (Ryan and Rosenfeld, 1997) .
POU transcription factors regulate the expression of target genes during animal development (for a review see Ryan and Rosenfeld, 1997) . During murine development, a number of octamer-binding proteins are expressed ubiquitously, some others are expressed in a cell-specific manner (for a review see Schöler, 1991) . For example, Oct-2 is expressed in B cells where it activates the immunoglobulin promoter and participates in B-cell maturation (Gstaiger et al., 1995; Strubin et al., 1995) . Oct-6 is expressed in Schwann cells by embryonic age 16 and participates in the myelinization process of nerve fibers during mouse postnatal development (Jaegle et al., 1996) .
Oct-4 mRNA and protein are present in the unfertilized, fully-grown oocyte. Oct-4 mRNA levels are reduced during the first two cleavage stages and then steadily upregulated before the 8-cell stage. Oct-4 protein expression follows a similar pattern. During the first cleavages of the embryos it is low expressed and is upregulated coincident with the activation of the zygotic genome (Schöler et al., 1990a; Palmieri et al., 1994) . Thereafter, Oct-4 expression is restricted to the blastocyst stem cell population (inner cell mass, ICM). After implantation, Oct-4 expression is confined to the epiblast compartment until the beginning of gastrulation, when it is downregulated progressively in an anterior to posterior manner (Rosner et al., 1990) . Although the signalling pathway leading to Oct-4 downregulation in the epiblast at the time of gastrulation has not yet been identified, by age 7.5-8.0 (days post coitum) dpc, primordial germ cells (PGCs) represent the only embryonal cell type expressing this transcription factor (Rosner et al., 1990; Schöler at al., 1990a,b) .
Oct-4 gene activity is driven by a 'distal' element (called distal enhancer, DE) in the ICM and PGCs and by a 'proximal' element (called proximal enhancer, PE) in the epiblast . Interestingly, the shift in Oct-4 gene activity from the PE to the DE in the small group of cells committed to become PGCs is apparently coincident with the allocation of these cells to the extraembryonic region (the extraembryonic mesoderm), where they are initially confined in embryogenesis (for a review, see Lawson and Hage, 1994; Yeom et al., 1996; Tam and Zhou, 1996) .
In the mouse embryo, germ cells are initially located at the base of the allantois at 8.5 dpc. They are recognizable as a small cluster of alkaline phosphatase/c-kit-positive cells (for a review see Lawson and Hage, 1994) . Carried passively to the hindgut wall, they then actively migrate along the dorsal mesentery towards an area located on the coelomic border, the site of gonadal differentiation (McLaren and Buehr, 1990; Hogan, 1993) . During the migratory and the early gonadal periods, germ cells proliferate (Tam and Snow, 1981) . At 13.5 dpc, both female and male germ cells arrest their proliferation. While male germ cells are arrested in the G1 phase of the cell cycle (Vergouwen et al., 1991; Coucouvanis and Jones, 1993) , female germ cells enter into the prophase of the first meiotic division (De Felici and McLaren, 1983) .
Oogenesis and spermatogenesis are the gamete differentiation processes which, in mammals, involve a number of maturation steps of the germ cells, as well as the differentiation of ovarian and testicular structures (the follicle and the seminiferous epithelium, respectively) which sustain this process (reviewed in Hoog, 1995; Eppig et al., 1996) . The onset of gametogenesis is characterised in both sexes by meiosis, which allows genetic recombination and reduction of gamete ploidy.
Several studies have shown expression of Oct-4 in PGCs until 12 dpc in embryos (Schöler et al., 1989 (Schöler et al., , 1990a Rosner et al., 1990; Yeom et al., 1996) and in the adult females in unfertilized fully-grown oocytes (Schöler et al., 1989; Palmieri et al., 1994) . The aim of this study was to analyze the expression of Oct-4 in germ cells during oogenesis and spermatogenesis, from their embryonal proliferation stage through to adult stages. We found that in females, Oct-4 is downregulated during prophase I to be again expressed in oocytes within primary follicles and at the onset of oocyte growth and folliculogenesis. The analysis performed on the stages of male germ cell differentiation in embryonic, newborn and adult mice revealed that Oct-4 is downregulated in proliferating spermatogonia prior to entry into prophase I and is not expressed in the maturation stages of spermatogenesis. These results suggest a possible involvement of Oct-4 in the initiation of meiosis in both sexes and in the growth and the acquisition of competence to resume meiosis in oocytes.
Results

Oct-4 is expressed in proliferating PGCs in embryonic gonads of both sexes, but it is specifically downregulated at the onset of prophase I in female germ cells
In previous studies, Oct-4 RNA expression was found in proliferating PGCs by in situ hybridization in the genital ridges until 11.5-12.5 dpc (Rosner et al., 1990 : Schöler et al., 1990a Yeom et al., 1996) . In the present study, immunocytochemical analysis was performed on sections of foetal and newborn ovaries and testis using purified polyclonal antibodies against Oct-4. Oct-4 protein expression was found in the nuclei of proliferating PGCs present in undifferentiated genital ridges at 11.5 dpc and in developing ovaries and testes at 12.5 dpc and 13.5 dpc (Fig.  1) .
The analysis was then extended to sections of foetal testis and ovaries beyond age 14.5 dpc. The expression of Oct-4 was maintained in the now mitotically-arrested, post-proliferative prospermatogonia, while in the oocytes it was downregulated coincident with their entry into meiotic prophase I (Fig. 2) . At this stage, Oct-4 was expressed by only some clusters of germ cells within the ovary, whereas the majority of them had already lost Oct-4 expression ( Fig. 2A) . This is probably due to the unsynchronised arrest of proliferation and entry into meiosis of mouse oocytes (De Felici and McLaren, 1983) . At 16.5 dpc, coincident with the occurrence of zygotene/pachytene stage of prophase I of meiosis (De Felici and McLaren, 1983) , no Oct-4 expression was detectable in the oocyte population (Fig. 2B) .
The PGC-specific Oct-4 expression and downregulation was then analysed by electrophoretic mobility shift assay (EMSA) and reverse transcription polymerase chain reaction (RT-PCR) protein extracts and total RNA obtained from pools of germ cells purified as described in De Felici and McLaren (1982) and/or entire gonads. The EMSA (Fig.  3 ) and Western blot (not shown) experiments showed that Oct-4 was expressed at comparable levels in PGCs in both sexes until 13.5 dpc, and was downregulated in zygotene/ pachytene female germ cells at 16.5 dpc. In contrast, male germ cells still expressed Oct-4 at this age.
Differentiation of ES and EC cells by retinoic acid correlates with transcriptional repression of the Oct-4 gene (Pikarsky et al., 1994; Sylvester and Schöler, 1994; Ben-Shushan et al., 1995; Minucci et al., 1996) . To assess whether in female meiotic germ cells Oct-4 is subjected to transcriptional or translational regulation, we performed RT-PCR on 11.5-16.5 total RNA from populations of purified PGCs and entire gonads of 17.5-18.5 dpc embryos (Fig. 4) . In female germ cells, Oct-4 transcription decreased coincidentally with the entry into meiosis at 14.5 dpc, in parallel with the downregulation of the protein. This indicated that the downregulation of Oct-4 probably occurs at the transcriptional level.
Oct-4 is re-expressed before the beginning of the oocyte growth
Oct-4 protein is expressed in oocytes at the terminal stage of their differentiative process, prior to fertilization (Schöler et al., 1990b; Palmieri et al., 1994 ). An immunocytochemical analysis performed on sections of different stages of postnatal development of the ovary revealed that Oct-4 is expressed at low levels in the cytoplasm of oocytes of newborn females at 1 day post partum (dpp) (Fig. 5A ). These oocytes are still in the diplotene/dictyate stage and will not Fig. 3 . EMSA performed using protein extracts from isolated PGCs and 32 P-labelled oligo 1W containing the octamer motif binding sequence (Schöler et al., 1989) . The position of the complexes is coincident with the previously-determined migration of Oct-1, Oct-6 and Oct-4 (Schöler et al., 1990a) . The band corresponding to Oct-4 is undetectable in extracts from 16.5 dpc meiotic prophase I oocytes. Fig. 4 . RT-PCR assay on RNA from isolated PGCs. Total RNA was reverse-transcribed and subjected to PCR amplification as described in Section 4. Two bands of 310 bp and 460 bp corresponded to the amplification of Oct-4 and bactin mRNA respectively. Lane C shows the control reaction done omitting the reverse transcription. progress to the first meiotic division until they reach the fully-grown oocyte stage and are stimulated by gonadotropin, triggering their transition to the metaphase of the second meiotic division (Harthshorne et al., 1994) . Oct-4 protein expression appeared to be upregulated in oocytes within primordial follicles, in growing oocytes in bi/trilaminar follicles at 12 dpp and 14 dpp ( Fig. 5B and C, respectively) and in fully-grown oocytes in adult females (not shown; Palmieri et al., 1994) . The low cytoplasmic expression of Oct-4 in the oocytes at 1 dpp is consistent with previous observations in preimplantation embryos, in which the upregulation of Oct-4 in the nuclei of blastomeres at the 8-cell stage is preceded by lower cytoplasmic expression in the 4-cell cleavage stage (Palmieri et al., 1994) .
Oct-4 expression in the male germline is confined to the most undifferentiated spermatogonia
The immunocytochemical analysis of the foetal stages demonstrated that Oct-4 was expressed in mitoticallyarrested prospermatogonia until birth (Fig. 2C,D) . To investigate whether Oct-4 undergoes a meiosis entry-specific downregulation in male germ cells similar to that seen in the female, we analyzed Oct-4 expression in different stages of postnatal spermatogenic progression by immunocytochemistry. Oct-4 was detected in the entire population of spermatogonia in newborn male mice at 1 dpp and 7 dpp ( Fig. 6A and B) . These germ cells represent undifferentiated spermatogonia and constitute the stem cell population of germ cells within the testis (Bellve', 1979) .
The analysis of seminiferous tubules sections in later stages of postnatal development revealed that Oct-4 expression was still confined to the most undifferentiated spermatogonia even after the onset of spermatogonial proliferation. The position of the positively-stained cells within the seminiferous epithelium and their morphology at 17 dpp suggest that these cells represent type A spermatogonia (Fig. 7A,B ; Bellve', 1979) . In contrast, proliferating B spermatogonia, as well as primary leptotene/zygotene/pachytene spermatocytes, were Oct-4-negative. Finally, in the adult testis, Oct-4 was expressed by none of the different meiotic germ cell types and appeared to be confined to the type A spermatogonia population (Fig. 7C) .
Thus, in the testis, Oct-4 is downregulated at the entry of the germ cells into the committed programme of spermatogenetic proliferation rather than at the entry into meiosis per se. Conversely, the upregulation of this factor in the oocytes at the completion of meiotic prophase I suggests an additional function during oogenesis.
Discussion
In both sexes Oct-4 downregulation coincides with the commitment to meiosis
During the proliferative stages, PGCs express Oct-4 protein both in testes and ovaries. At the initiation of the meiotic prophase I in oocytes, and prior to the entry into meiosis of B spermatogonia, Oct-4 is downregulated. The RT-PCR analysis performed on RNA extracted from purified germ cells (Fig. 4) revealed that Oct-4 gene downregulation in female germ cells is probably due to transcriptional repression, although the involvement of post-transcriptional regulation cannot be excluded.
The function of the promoter and two enhancers regulating Oct-4 expression has been analyzed in several studies (Okazawa et al., 1991; Pikarsky et al., 1994; Yeom et al., 1996) . Using transgenic mice, it has been shown that the activity of both enhancers is differently regulated during mouse embryogenesis. In particular, the distal enhancer is specifically active in the ICM in the early embryo and in the population of PGCs, whereas the proximal element is epiblast-specific ; see also Section 1). Experiments in which differentiation was induced by retinoic acid suggested that in ES and EC cells Oct-4 downregulation could be controlled by a two-step mechanism. A first step appears to involve transrepression due to recruitment of nuclear receptors to the promoter containing three direct repeats to which such nuclear factors could bind (Syl- vester and Ben-Shushan et al., 1995) . A second step could involve modification of the chromatin structure within the Oct-4 upstream region and loss of occupancy of promoter/enhancer binding sites (Ben-Shushan et al., 1993; Minucci et al., 1996) .
The distal enhancer element is required for Oct-4 expression in PGCs . We speculate that this element might also be specifically required for the expression of this transcription factor in undifferentiated spermatogonia and maturing oocytes. From the data presented here, we are not able to conclude whether the Oct-4 repression during gametogenesis might be due to chromatin modification or by expression of repressors downregulating the Oct-4 gene in a stage-specific manner. Interestingly, GCNF, a germ cell-specific orphan receptor (Chen et al., 1994) , exhibits a pattern of expression that suggests it could be involved in regulating the activity of the Oct-4 promoter.
Is the Oct-4 downregulation in germ cells involved in the initiation of meiosis?
Meiosis is a feature unique to germ cells in all eukaryotes. The control of the meiotic process has been investigated in different animal models. Several genes, expressed by meiotic germ cells, encode factors supposed to participate in specific maturation events of sperms and oocytes (for references see Wolgemuth and Watrin, 1991; Hoog, 1995; Sagata, 1996) . For example, the involvement of the c-mos protein kinase has been shown to function in the phosphorylation cascade regulating the block and subsequent resumption of meiosis (for references see Sagata, 1997) and DNA mismatch-repair proteins appear to be involved in genetic recombination events taking place in synaptonemal complexes (Meuwissen et al., 1992; Baker et al., 1996; Edelmann et al., 1996) . Furthermore, several transcription factors have been identified that appear to be specifically expressed during meiosis mostly in male germ cells (for references, see Noce et al., 1992; Trauth et al., 1994; Hoog, 1995; Nantel et al., 1996) .
Several genes are thought to be regulated by Oct-4 in ES and EC cells and during early embryogenesis. For example, Oct-4 has been implicated in the regulation of the expression of FGF-4 in EC F9 cells (Dailey et al., 1994; Rizzino and Rosfjord, 1994 ) and the REX-1 zinc finger transcription factor in EC and ES cells . More recently Oct-4 has been proposed also as a potential , the cells expressing Oct-4 are seen to be distributed at the periphery of the seminiferous epithelium (arrowheads). Their distribution within the seminiferous epithelium, and their shape, suggests that they represent undifferentiated A spermatogonia (Russel et al., 1990) . Note that pachytene spermatocytes (arrows) are Oct-4 negative. In the adult testis (panel C), none of the spermatogenetic cells types except type A spermatogonia (arrowheads) expresses Oct-4. B spermatogonia (arrows), meiotic primary (l,p) and secondary (s) spermatocytes, as well as spermatids, are negative. The observed staining at the adluminal region of the seminiferous epithelium was not abolished by incubation of the primary antibody with recombinant Oct-4 protein (not shown), suggesting that it could result from non-specific binding of the secondary antibody. Bars indicate 200 and 50 mm in A and B,C panels respectively.
repressor of the expression of human bHCG hormone in choriocarcinoma cells (Liu and Roberts, 1996) , thus indicating that the function of this factor in embryogenesis could depend upon the promoter context or different sets of cofactors (Yuan et al., 1995; Liu and Roberts, 1996) .
The expression of Oct-4 in ES and EC cells and probably during early embryogenesis appears to be linked to the maintenance of the undifferentiated phenotype (Shimazaki et al., 1993) . It is thus likely that Oct-4 could also fulfill this primary function during the first steps of germline differentiation , when a small group of cells in the proximal part of the epiblast are allocated outside the embryo at the base of the allantoic bud to become PGCs (Tam and Zhou, 1996) and during the early gonadal period of either male and female PGCs. Its expression in undifferentiated spermatogonia in the testis could prevent the differentiation of these cells. On the other hand, the striking correlation between Oct-4 downregulation and the entry into meiosis of germ cells, suggests that this event might represent one of the molecular triggers involved in the meiotic progression in both sexes.
Some studies have suggested that the entry into meiosis of germ cells is not a cell-autonomous event but, rather, might be regulated by factors produced by somatic cells within the gonad. For example, a diffusible factor (meiotic preventing substance, MPS) synthesised in the male gonad might prevent prospermatogonia from undergoing meiosis (Byskov, 1978) . Experiments using chimeric gonads obtained by reaggregating female germ cells together with male gonadal somatic cells of the same age have shown that the male gonadal environment prevents oogonial meiotic entry (Dolci and De Felici, 1990 ). However, prospermatogonia removed by male gonadal environment and aggregated with a heterologous tissue, progress into meiotic prophase I like oocytes (McLaren and Southee, 1997) . In this light, the possibility that Oct-4 expression in germ cells could be regulated in a sex-specific manner by the somatic compartment within the gonads appears particularly intriguing.
The de novo expression of Oct-4 in oocytes is coincident with the events preceding the end of meiotic prophase I
The Oct-4 expression pattern in the oocytes is different from that found in the male germ cells after the end of meiotic prophase I. In particular, in the testis, Oct-4 expression is confined to the most undifferentiated spermatogonia and is not found in germ cells in subsequent stages of maturation. In contrast, oocytes start to re-express Oct-4 preceding the end of meiotic prophase I. This suggests that this factor could play additional role(s) in oocyte growth and the acquisition of the competence to resume meiosis.
A striking difference between meiosis in the two sexes is that in males, the two rounds of meiotic division of spermatogenetic cells are continuous, while during oogenesis oocytes are blocked in the diplotene/dictyate stage of the prophase of the first meiotic division. They rest in this stage until puberty, when small pools are cyclically recruited to grow. This maturation phase allows oocytes to acquire the specific competence to resume meiosis and to progress to the metaphase of the second meiotic division (Eppig et al., 1996) .
Some of the signals involved in mouse oocyte maturation have been elucidated at the molecular level. For example, stimulation by growth factor stem cell factor (SCF) is believed to play a role in oocyte growth (Packer et al., 1994; De Felici et al., 1996) . Interestingly, the expression of the SCF receptor, the c-kit tyrosine kinase, appears to be downregulated during the initial stages of prophase I, to be again expressed at the onset of oocyte growth (De Felici et al., 1996) . Furthermore, specific signals control oocyte progression through meiosis. For example, the expression of the protein kinase c-mos in the oocyte activates a mitogen-activated protein kinase (MAPK)-dependent cascade believed to be one of the initial triggers promoting the prophase I to metaphase II transition. C-mos expression is upregulated during oocyte growth, before the oocytes acquire the competence to resume meiosis (for a review, see Sagata, 1997) . Given the pattern of expression of Oct-4 in female germ cells, it is possible that the expression of these and other factors involved in the oocyte maturation steps could be controlled by this transcription factor. In such a case, Oct-4 would have different functions during distinct stages of oogenesis, possibly controlling the expression of target genes involved in the oocyte maturation process. Inducible overexpression experiments of Oct-4 in vivo might help in understanding the function of Oct-4 in mouse gametogenesis.
Experimental procedures
Immunocytochemistry
Swiss Webster mice, purchased from Charles River (Wilmington, DE), were mated to obtain embryos from 11.5 to 18.5 dpc of gestation, with day 0.5 being the day of detection of the vaginal plug. To determine the sex of the embryos, genomic DNA was isolated from the placenta of 11.5 to 15.5 dpc embryos, digested with Eco RI and subjected to Southern blot analysis according to our standard procedures (Wolgemuth et al., 1989) . The blots were hybridized with a Y chromosome-specific probe labelled with digoxigenin-11-dUTP (DIG/Genius TM 1 DNA labelling and detection kit, Boehringer Mannheim).
Whole embryos at 11.5 to 15.5 dpc were fixed with 4% buffered paraformaldehyde, then processed and embedded in paraffin by our standard methods for paraffin sectioning (Chapman and Wolgemuth, 1994) . For the embryos from 16.5 to 18.5 dpc and postnatal and adult stages, testis and ovaries were dissected from embryos or newborns and adult mice and fixed with 4% paraformaldehyde, processed and embedded in paraffin.
Purified rabbit polyclonal antibodies against Oct-4 were those described previously (Palmieri et al., 1994) and were used at 2 mg/ml. The avidin-biotinylated-peroxidase complex (ABC) was used to detect the bound antibodies on histological sections. (Vectastain ABC kit, Vector Laboratory, Burlingame, CA). Prior to incubation with the primary antibody, rehydrated sections were first microwaved for 10 min in 0.01 M citric acid and then washed twice with double-distilled water. Endogenous peroxidase activity was abolished by incubating sections in methanol containing 0.3% H 2 O 2 for 20 min. After a wash with 1× phosphatebuffered saline with 0.01% Triton X-100 (PBST), sections were blocked by preincubating with blocking solution: 3% normal goat serum in 1× PBST for 1 h at room temperature (RT). Sections were incubated with primary antibody at 4°C overnight. The sections were rinsed with 1× PBST three times followed by incubation with biotinylated horse antirabbit IgG (1:200) for 2 h at RT. After a wash in 1× PBST, the sections were incubated in ABC reagent in 1× PBST for 2 h at RT followed by a wash in 1× PBST. Sections were then equilibrated in 0.1 M Tris, pH 7.2, for 5 min. Immunostaining was visualized using 0.2 mg/ml diaminobenzidine and 0.01% H 2 O 2 in 0.1 M Tris, pH 7.2. The sections were counterstained with haematoxylin and coverslipped using Protexx mounting media (Baxter, Deerfield, IL). Specific competition experiments using purified bacterial Oct-4 protein were performed in order to test the antibody specificity. The 1.0-ml mixture of antibody (0.5 mg) and Oct-4 protein was incubated (40 mg) at RT for 1 h and was followed by the procedures described above.
Protein methods
Proteins were extracted from PGCs purified as described in De Felici and McLaren, 1982 . Briefly, embryos form 11.5 to 18.5 dpc were dissected in M2 medium (Hogan et al., 1986) . For isolation of PGCs, 11.5-to 16.5-dpc gonads were incubated in 0.05% EDTA in PBS (Ca-and Mg-free) for 10-20 min at RT. After incubation, the gonads were transferred into fresh M2 medium and mechanically disaggregated with needles under the microscope, and PGCs collected with a mouth-operated glass pipette. Collected cells and gonads were lysed in a buffer containing 150 mM NaCl, 0.2 mM EDTA, 20 mM Hepes, pH 7.8, 25% glycerol, 100 mM DTT, and protease inhibitors (100 mM PMSF, 0.5 mg/ml Leupeptin, 0.7 mg/ml Pepstatin and 2 mg/ ml Aprotinin). EMSA experiments were performed by incubating, for 30 min, 1 mg PGC proteins in a buffer containing 125 mM Hepes, pH 7.6, 2.5 mM EDTA, 2.5 mM DTT, 50% glycerol 250 mM NaCl, 2 mM DTT and 1 mg poly dIdC with approximately 10 fmol of an oligo containing the octamer motif (ATGCAAAT) binding sequence (Schöler et al., 1989) which was end-labelled with 1 U of Klenow enzyme in a reaction containing 50 mM dATP, dGTP, dTTp and 25 mCi 32 PdCTP (specific activity 10 mCi/mmol). After the binding reaction, the complexes were separated by electrophoresis on a 5% polyacrylamide native gel.
RNA methods
Total RNA was obtained from 11.5 to 16.5 dpc PGCs isolated as described above or from 17.5 to 18.5 total gonads. RNA was extracted by RNAzol reagent (CinnaBiotecx) according to the manufacturer's instructions. For RT-PCR, 1 mg of total RNA was reverse transcribed in a mixture containing random hexamers at 12.5 pmol/ml, 1 U/ ml and 10 U/ml M-MLV reverse transcriptase (Promega). PCR reaction was performed using a 30-cycle program consisting of 1 min at each 94°C, 55°C and 72°C in a mixture containing 2.5 U/reaction AmpliTaq DNA polimerase (Perkin-Elmer). Primers sense CTCGAACCACATCCTTCTCT and antisense GGCGTTCTCTTTGGAAAGGTGTTC were used to specifically amplify Oct-4 cDNA. In the same reaction tubes, sense GGCCCAGAGCAAGAGAGGTATCC and antisense AGCCACGATTTCCCTCTCAGC primers for bactin cDNA amplification were added as internal controls of the PCR reaction. In all the PCR experiments a negative control in which the RNA was not subjected to reverse transcription was included (see Fig. 4 ).
